The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive value of IDH1 mutation assessed by immunohistochemistry and DNA sequencing in WHO grade 3 oligodendrogliomas.
J. Frenel
No relevant relationships to disclose
C. Leux
No relevant relationships to disclose
D. Loussouarn
No relevant relationships to disclose
A. Le Loupp
No relevant relationships to disclose
F. Leclair
No relevant relationships to disclose
A. Von Deimling
No relevant relationships to disclose
M. Aumont
No relevant relationships to disclose
S. Martin
No relevant relationships to disclose
M. G. Denis
No relevant relationships to disclose
M. Campone
No relevant relationships to disclose